Antiemetics And Antinauseants Market Expansion to $9.64 Billion by 2029: Key Drivers and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the antiemetics and antinauseants market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Antiemetics And Antinauseants Market Today And What Will It Reach By 2029?

The antiemetics and antinauseants market has shown consistent expansion in recent times. It is projected to increase from $8.19 billion in 2024 to $8.48 billion in 2025, at a compound annual growth rate (CAGR) of 3.6%. The growth witnessed during the historic period can be attributed to historical branding and market competition, historical treatment preferences, economic conditions, historical global health events, medical advancements and research.

The antiemetics and antinauseants market is projected to experience consistent expansion over the upcoming years. This market is forecast to reach $9.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.3%. During the forecast period, this expansion is anticipated due to factors such as research and development efforts, economic conditions, competitive market dynamics and industry developments, evolving disease trends, and healthcare policies and regulatory frameworks. Key trends anticipated for this period encompass a heightened emphasis on patient experience, shifts in healthcare policies, a growing consumer inclination towards non-invasive therapies, an increase in chemotherapy and pregnancy-induced nausea cases, and the development of targeted treatments.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Factors Are Boosting The Antiemetics And Antinauseants Market?

The antiemetics and antinauseants market expands with the increasing prevalence of cancer. Chemotherapy, a widely recommended treatment for cancer, frequently causes side effects such as chemotherapy-induced nausea and vomiting (CINV), which antiemetics can prevent in approximately 60%-70% of patients. For illustration, in April 2024, The American Cancer Society, a non-profit organization headquartered in the United States, projected around 609,000 cancer-related deaths and an estimated 1.9 million new cancer cases identified in the country in 2022. A modest increase in mortality rates is expected in 2024, with an anticipated 620,000 cancer deaths. This rising cancer incidence will escalate the demand for antiemetics and antinauseants, thereby boosting the market’s revenue.

How Is The Antiemetics And Antinauseants Market Categorized By Application, Type, And Region?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Technological Trends Affecting The Antiemetics And Antinauseants Market Growth?

Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as ready-to-use injectables, to streamline treatment processes and enhance patient compliance. These pre-prepared formulations are designed to deliver immediate effectiveness, reducing the time and complexity associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based specialty pharmaceutical company, launched FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant, designed to prevent acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and does not require reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has been assigned a unique J-Code (J1434) for reimbursement.

Who Are The Global Leaders Steering The Antiemetics And Antinauseants Market Forward?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Organ On Chip Market 2025

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795